Figure 2.

Cumulative changes in demand for lung cancer therapy in the United States between 2015 and 2040 with the implementation of low‐dose computed tomography screening for lung cancer in 2018. The data are expressed as cumulative percentage changes in comparison with no screening. All policies assumed a constant 50% adherence to screening. CMS indicates Centers for Medicare and Medicaid Services recommendations (annual screening of current smokers and former smokers who quit fewer than 15 years ago, aged 55‐77 years, with a smoking history of at least 30 pack‐years); Ontario, most cost‐effective policy from a study for Cancer Care Ontario (annual screening of current smokers and former smokers who quit fewer than 10 years ago, aged 55‐75 years, with a smoking history of at least 40 pack‐years); USPSTF, US Preventive Services Task Force recommendations (annual screening of current smokers and former smokers who quit fewer than 15 years ago, aged 55‐80 years, with a smoking history of at least 30 pack‐years).